244 related articles for article (PubMed ID: 27566854)
1. Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.
Muzychuk AK; Robert MC; Dao S; Harissi-Dagher M
Ophthalmology; 2017 Jan; 124(1):20-26. PubMed ID: 27566854
[TBL] [Abstract][Full Text] [Related]
2. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
Robert MC; Biernacki K; Harissi-Dagher M
Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
[TBL] [Abstract][Full Text] [Related]
3. Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes.
Sabeti S; Daoud R; Robert MC; Harissi-Dagher M
Can J Ophthalmol; 2022 Apr; 57(2):127-133. PubMed ID: 33781724
[TBL] [Abstract][Full Text] [Related]
4. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
[TBL] [Abstract][Full Text] [Related]
5. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
6. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
[TBL] [Abstract][Full Text] [Related]
7. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
[TBL] [Abstract][Full Text] [Related]
8. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
[TBL] [Abstract][Full Text] [Related]
9. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
Aravena C; Yu F; Aldave AJ
Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
[TBL] [Abstract][Full Text] [Related]
11. Boston type 1 keratoprosthesis: the CHUM experience.
Robert MC; Harissi-Dagher M
Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
[TBL] [Abstract][Full Text] [Related]
12. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
13. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
14. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
15. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
[TBL] [Abstract][Full Text] [Related]
17. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
Aoun T; Harissi-Dagher M
J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
[TBL] [Abstract][Full Text] [Related]
18. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
19. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
[TBL] [Abstract][Full Text] [Related]
20. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]